Report cover image

Global Bioanalytical Testing Services in CRO Market Size Study, By Molecule (Small, Large), By Test (Bioavailability, Bioequivalence, ADME, Biomarker Testing, Cell-based Assay, Virology Testing, Other Tests), By Workflow (Sample Collection & Preparation,

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464082

Description

The Global Bioanalytical Testing Services in CRO Market was valued at USD 3.35 billion in 2024 and is expected to expand at a CAGR of 9.5% from 2024 to 2034. The rapid expansion of biopharmaceutical research, the rising complexity of biologics and biosimilars, and stringent regulatory requirements are key drivers of this market. Bioanalytical testing services in Contract Research Organizations (CROs) provide an essential function in the drug development process, ensuring drug safety, efficacy, and regulatory compliance. Increasing pharmaceutical R&D expenditures, coupled with the rising demand for outsourcing bioanalytical services, further strengthen the market growth.

The rising prevalence of chronic diseases and the increasing number of clinical trials have resulted in higher demand for bioanalytical services globally. CROs specializing in bioanalytical testing offer specialized expertise in mass spectrometry, chromatography, ligand binding assays, and genomic analysis, supporting the pharmaceutical industry's need for faster and more cost-efficient drug development. The growing adoption of advanced technologies, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), immunoassays, and digital laboratory solutions, has also accelerated the market expansion.

The market's growth is further bolstered by the expansion of CROs in emerging markets, particularly in Asia-Pacific and Latin America, where regulatory landscapes are evolving to align with global standards. Major pharmaceutical firms are increasingly partnering with bioanalytical CROs to streamline drug development, optimize costs, and enhance efficiency. Additionally, stringent guidelines from regulatory agencies like the FDA, EMA, PMDA, and ICH have heightened the need for advanced method development, validation, and pharmacokinetic (PK) testing, increasing CRO engagement.

Regionally, North America dominates the market due to its strong presence of pharmaceutical and biotechnology companies, high R&D investments, and well-established CROs offering cutting-edge bioanalytical services. However, Asia-Pacific is expected to witness the fastest CAGR due to low operational costs, increasing outsourcing of clinical trials, and advancements in biosimilar research. The European market is driven by strict regulatory standards and growing collaborations between biotech firms and CROs. Meanwhile, Latin America and the Middle East & Africa are also experiencing steady market expansion due to rising clinical research activities and investments in healthcare infrastructure.

Major Market Players Included in this Report:
  • Thermo Fisher Scientific Inc.
  • ICON Plc
  • Charles River Laboratories International
  • Wuxi AppTec
  • IQVIA
  • Syneos Health
  • SGS SA
  • Labcorp
  • Intertek Group Plc
  • Pace Analytical Services LLC
  • Medpace
  • BioAgilytix Labs
  • PPD Inc.
  • Frontage Laboratories
  • Covance
The Detailed Segments and Sub-segments of the Market are Explained Below:

By Molecule:
  • Small Molecule
  • Large Molecule
  • LC-MS Studies
  • Immunoassays
  • Pharmacokinetics (PK)
  • ADA Assay
  • Others
By Test:
  • ADME
  • In-Vivo
  • In-Vitro
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Bioavailability
  • Bioequivalence
  • Biomarker Testing
  • Cell-based Assay
  • Virology Testing
  • Other Tests
By Workflow:
  • Sample Collection & Preparation
  • Sample Collection, Handling & Storage
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
  • Others
  • Method Development & Validation
  • Sample Analysis
  • Hyphenated Techniques
  • Chromatographic Techniques
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Spectroscopic Techniques
  • Nuclear Magnetic Resonance (NMR)
  • Others
  • Genomic & Molecular Techniques
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Others
  • Other Workflow Processes
By End Use:
  • Pharma & Biopharma Companies
  • Academic & Research Institutes
  • Others
By Region:

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Netherlands
  • Switzerland
Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Malaysia
  • Singapore
  • Taiwan
Latin America
  • Brazil
  • Argentina
  • Colombia
Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Israel
Years Considered for the Study:
  • Historical Year – 2022
  • Base Year – 2024
  • Forecast Period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2034.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed geographical landscape with country-level market insights.
  • Competitive landscape with major player profiles, key strategies, and revenue analysis.
  • Analysis of key business strategies and recommendations on future market approach.
  • Demand-side and supply-side analysis of the market, identifying growth trends and potential investment opportunities.

Table of Contents

285 Pages
Chapter 1. Global Bioanalytical Testing Services in CRO Market Executive Summary
1.1. Global Bioanalytical Testing Services in CRO Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Molecule
1.3.2. By Test
1.3.3. By Workflow
1.3.4. By End Use
1.4. Key Market Trends
1.5. Recession Impact
1.6 Industry Metrics
1.7 Investment Analysis
1.8 Investment Rationale
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Bioanalytical Testing Services in CRO Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Bioanalytical Testing Services in CRO Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Pharmaceutical & Biopharmaceutical R&D Expenditures
3.1.2. Growing Complexity of Biologics & Biosimilars
3.1.3. Stringent Regulatory Requirements for Drug Development
3.1.4. Technological Advancements in Bioanalytical Testing
3.2. Market Challenges
3.2.1. High Costs of Bioanalytical Testing
3.2.2. Regulatory Compliance & Changing Guidelines
3.2.3. Shortage of Skilled Workforce in Bioanalytical Testing
3.3. Market Opportunities
3.3.1. Expansion of CROs in Emerging Markets
3.3.2. Increasing Demand for Personalized Medicine
3.3.3. Rising Outsourcing Trend in Bioanalytical Testing
Chapter 4. Global Bioanalytical Testing Services in CRO Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends in the Market
4.6. Industry Expert Perspective
4.7. Analyst Recommendations & Conclusion
Chapter 5. Global Bioanalytical Testing Services in CRO Market Size & Forecast by Molecule (2024-2034)
5.1. Segment Dashboard
5.2. Global Bioanalytical Testing Services in CRO Market by Molecule Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Small Molecule
5.2.2. Large Molecule
5.2.2.1. LC-MS Studies
5.2.2.2. Immunoassays
5.2.2.3. Pharmacokinetics (PK)
5.2.2.4. ADA Assay
5.2.2.5. Others
Chapter 6. Global Bioanalytical Testing Services in CRO Market Size & Forecast by Test (2024-2034)
6.1. Segment Dashboard
6.2. Global Bioanalytical Testing Services in CRO Market by Test Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. ADME
6.2.2. In-Vivo
6.2.3. In-Vitro
6.2.4. Pharmacokinetics (PK)
6.2.5. Pharmacodynamics (PD)
6.2.6. Bioavailability
6.2.7. Bioequivalence
6.2.8. Biomarker Testing
6.2.9. Cell-based Assay
6.2.10. Virology Testing
6.2.11. Other Tests
Chapter 7. Global Bioanalytical Testing Services in CRO Market Size & Forecast by Workflow (2024-2034)
7.1. Segment Dashboard
7.2. Global Bioanalytical Testing Services in CRO Market by Workflow Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Sample Collection & Preparation
7.2.1.1. Sample Collection, Handling & Storage
7.2.1.2. Protein Precipitation
7.2.1.3. Liquid-Liquid Extraction
7.2.1.4. Solid Phase Extraction
7.2.1.5. Others
7.2.2. Method Development & Validation
7.2.3. Sample Analysis
7.2.3.1. Hyphenated Techniques
7.2.3.2. Chromatographic Techniques
7.2.3.3. Electrophoresis
7.2.3.4. Ligand Binding Assay
7.2.3.5. Mass Spectrometry
7.2.3.6. Spectroscopic Techniques
7.2.3.7. Nuclear Magnetic Resonance (NMR)
7.2.3.8. Others
7.2.4. Genomic & Molecular Techniques
7.2.4.1. Polymerase Chain Reaction (PCR)
7.2.4.2. Next-Generation Sequencing (NGS)
7.2.4.3. Others
7.2.5. Other Workflow Processes
Chapter 8. Global Bioanalytical Testing Services in CRO Market Size & Forecast by End Use (2024-2034)
8.1. Segment Dashboard
8.2. Global Bioanalytical Testing Services in CRO Market by End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Pharma & Biopharma Companies
8.2.2. Academic & Research Institutes
8.2.3. Others
Chapter 9. Global Bioanalytical Testing Services in CRO Market Size & Forecast by Region (2024-2034)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Netherlands
9.2.7. Switzerland
9.3. Asia-Pacific
9.3.1. India
9.3.2. China
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Thailand
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Israel
9.5.5. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Thermo Fisher Scientific Inc.
10.1.2. ICON Plc
10.1.3. Charles River Laboratories International
10.2. Market Strategies
10.3. Company Profiles
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us